ADGM Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc. (ADGM) is expected to report earnings on November 10, 2026, before the market open. The consensus earnings estimate is a loss of $0.30 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.7% since its last earnings release on August 11, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Adagio Medical Holdings, Inc.
Adagio Medical is a developmental stage medical device company which focuses on developing cryoablation technologies which create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter and ventricular tachycardia. Adagio Medical, formerly known as ARYA Sciences Acquisition Corp IV, is based in LAGUNA HILLS, Calif.
Sector
Healthcare
Industry
Medical Instruments/Supply